FELECIA GREEN: Open Payments
NPI 1205914546 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 10 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $150 |
| Teva Pharmaceuticals USA, Inc. | 1 | $28 |
| Insulet Corporation | 1 | $26 |
| Lilly USA, LLC | 1 | $21 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| SANOFI PASTEUR INC. | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
Products named: AREXVY, AUSTEDO XR, SHINGRIX, Omnipod, MOUNJARO, TZIELD, AIRSUPRA, ZORYVE.
Industry payments across CA — which companies pay providers there.
